Cytokines can stimulate eosinophils t o produce cysteinyl leukotrienes (LTs) in the lung that provoke tissue destruction associated with asthma. Priming of an eosinophilic substrain of HL-60 cells (HL-60#7) with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) before ionophore challenge was found t o produce an apparent 45% increase in total LT production in a dose-dependent manner (EDso = 150 pmol/L) that could be accounted for by a decrease in the time required for maximal formation of LTs. GM-CS had no effect on the kinetic parameters of LTC, synthase and therefore probably acts upstream of this catalytic event. Incubation with interleukin-5 (IL-5). however, had no effect on LT biosynthesis. This differential priming ability was not a consequence of different receptor populations or EUKOTRIENES (LTs), which are derived through the 5-lipoxygenase pathway of arachidonic acid metabolism, are lipid mediators of inflammation and immediate hypersensitivity.'.' LTB4, a mediator of inflammation, has been shown to activate leukocytes, thus stimulating chemokinesis, chemotaxis, and cell adherence, whereas the cysteinyl LTs, LTC4, LTD4, and LTE, (which collectively comprise the slow-reacting substance of anaphylaxis), can induce bronchoconstriction, mucous hypersecretion, vasoconstriction, and vascular permeability changes and are thus thought to be important mediators of bronchial Because LTs have important pathologic implications, determining the mechanism by which their synthesis is regulated is of considerable interest.
Cytokines can stimulate eosinophils t o produce cysteinyl leukotrienes (LTs) in the lung that provoke tissue destruction associated with asthma. Priming of an eosinophilic substrain of HL-60 cells (HL-60#7) with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) before ionophore challenge was found t o produce an apparent 45% increase in total LT production in a dose-dependent manner (EDso = 150 pmol/L) that could be accounted for by a decrease in the time required for maximal formation of LTs. GM-CS had no effect on the kinetic parameters of LTC, synthase and therefore probably acts upstream of this catalytic event. Incubation with interleukin-5 (IL-5). however, had no effect on LT biosynthesis. This differential priming ability was not a consequence of different receptor populations or EUKOTRIENES (LTs), which are derived through the 5-lipoxygenase pathway of arachidonic acid metabolism, are lipid mediators of inflammation and immediate hypersensitivity.'.' LTB4, a mediator of inflammation, has been shown to activate leukocytes, thus stimulating chemokinesis, chemotaxis, and cell adherence, whereas the cysteinyl LTs, LTC4, LTD4, and LTE, (which collectively comprise the slow-reacting substance of anaphylaxis), can induce bronchoconstriction, mucous hypersecretion, vasoconstriction, and vascular permeability changes and are thus thought to be important mediators of bronchial Because LTs have important pathologic implications, determining the mechanism by which their synthesis is regulated is of considerable interest.
It has been shown that cytokines are not only involved in the differentiation and proliferation of pro-myelocytes, but that cytokines also modulate the activation of LT biosynthesis in mature myeloid cells.'"* Priming of eosinophils and other cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-5 (IL-5) has been shown to enhance LT production after stimulation with calcium ionophore through a mechanism that is incompletely understood.".I4 GM-CSF, IL-3, and IL-5 receptors all belong to the hematopoietic growth factor receptor superfamily. These heterodimeric receptors each consists of a cytokine-specific a-chain component and a common P-chain component."-*' The a-chain is believed to be responsible for the specific binding of the distinct ligands to each receptor and, in the absence of the &chain, is capable of binding the ligand with low affinity without signal transduction.'h*'8~'0-24 Both the achain and the P-chain, however, are required for high-affinity binding of the ligand to the receptor, resulting in activation of the signalling pathway, probably through the intracellular portion of the p -~h a i n . "~' '~~'~~~ An understanding of the ligand-receptor mechanism for upregulation of LTs in eosinophils is important because eosinophils are a major source of cysteinyl LT producti~n.~',~~ Evidence suggests that IL-5, which is released by activated T cells in the can activate mature pulmonary eosinophils. This can result in upregulation of the production of mediators such as LTs and free radicals and the release of differences in the affinity or stability of the ligand-receptor complexes of GM-CSF and IL-5. GM-CSF and 11-5 each displayed similar populations of high-affinity binding sites and neither GM-CSF nor IL-5 were able t o cross-compete for the other's receptor binding sites. Analysis of phosphotyrosine patterns suggest that IL-5 is incapable of transducing a signal in eosinophilic HL-60#7 cells even though IL-5 and GM-CSF receptors mediate signal transduction via a common &chain component that is also necessary for high-affinity binding. Overall, this unique system may permit the dissection of distinct events responsible for specific intracellular signals transduced separately by GM-CSF or IL-5. 0 1995 by The American Society of Hematology.
cytotoxic granule contents, including major basic protein. IL-5 can also serve to increase eosinophil migration into the lung by enhancing differentiation of myeloid precursor cells towards eosinophils and by acting as a chemotactic agent for circulating eosinophils."
In the present study, the effects of cytokines on a new eosinophilic cell line, HL-60#7, were investigated to ascertain the mechanism of regulation of LT biosynthesis in eosinophils.
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from BDH (Toronto, Ontario, Canada). Prostaglandin Bz (PGB,) was purchased from Cayman Chemical CO (Ann Arbor, Mi). The antiphosphotyrosine monoclonal antibody, 4G10, was from Upstate Biotechnology Inc (Lake Placid, NY). The enhanced chemiluminescence (ECL) kit and horseradish peroxidase-linked goat antimouse antibody were obtained from Amersham Life Sciences (Buckinghamshire, UK). Sodium dodecyl sulfate (SDS) and Tween-20 were from Bio-Rad (Richmond, CA). Triton X-100 and premade blocking buffer (Superblock) were purchased from Pierce. Sodium orthovanadate was from Fisher Scientific (Fair Lawn, NJ) and TridHC1 was from BRL (Gaithersburg, MD). All other reagents were of analytical grade and were purchased from Sigma.
Growth and DifSerentiation of Eosinophilic HL-60#7 Cells
The HL60/MF211#7 cell line (abbreviated HL-6W7 herein), a substrain of HL-60 cells with a high propensity for eosinophilic differentiation, has been developed by long-term subculturing under alkaline conditions and continuous selection of substrains expressing eosinophilic markers when cultured in the presence of butyric acid." This pro-eosinophilic cell line was propagated by subculturing at a seed density of 0.2 X IO6 cells/mL into fresh sterile RPM1 1640 (supplemented with 0.2% [wtlvol] sodium bicarbonate and 0.03% [wt/vol] L-glutamine) containing 50 U/mL penicillin, and 50 pg/mL streptomycin, and 10% (voYvol) fetal bovine serum (Sigma; HybriMax, not heat-inactivated). Cultures were grown at 37°C in a humidified atmosphere containing 6% CO, in either 175-cmZ culture flasks or spinner flasks (25 rpm). To differentiate the HL-60#7 cell line into eosinophilic cells, cultures were seeded at 0.2 X IO6 cells/mL in fresh medium (described above) and supplemented with 0.4 mmoY L n-butyric acid (added from a 150 mmol/L stock in ethanol). The cells were grown without further subculturing for up to 7 days. (Note that differentiation in spinner cultures lagged behind that in T-flasks by 1 to 2 days and that differentiated cells could not be propagated.) Cells were harvested by centrifugation at 500g for 15 minutes at room temperature. The resulting pellet was washed by resuspending the cells in Dulbecco's phosphate-buffered saline (dPBS) and resedimenting them at 500g for 15 minutes.
Cytokine Priming and Measurement of LT Production in
Ionophore-Challenged HL-60#7 Cells
Butyric aciddifferentiated HL-60#7 cells were harvested, washed with dPBS, and resuspended at 20 X 106 celldml in dPBS containing 1 mmollL EDTA and 1 mg/mL D-glucose. Unless otherwise indicated, cells were incubated with 200 pmom cytokine for 30 minutes at 37°C and then CaCI, (2 mmol/L final concentration) was added to the mixture, which was incubated for an additional 8 minutes with constant orbital shaking ( f i n a l v01 = 2 mL). Calcium ionophore, A23187, was added to a final concentration of 1 pmollL and the reaction was stopped after 3 minutes at 37°C by combining the mixture with an equal volume of ice-cold methanol containing 0.2 nrnoUmL PGB, (as an internal HPLC standard).
After allowing the terminated reaction mixture to stand for at least 15 minutes at 4"C, precipitated proteins were removed by centrifugation for 15 minutes at l50g at 4°C. The supernatant was diluted with HzO to a final volume of 10 mL and respun for 15 minutes at l50g at 4°C. LTs were purified from the resulting supernatant by applying it to a Sep-Pak CIS cartridge (Waters Associates) that had been preconditioned with 10 mL H20, 10 mL methanol, and then 10 mL H,O at a maximum flow rate of 1 mWmin. After washing the cartridge with 20 mL H,O, the bound LTs were eluted with 1 mL of methanol. The eluent was dried by vacuum centrifugation and resuspended in 200 pL HPLC mobile phase (acetonitrilexnethano1:water:acetic acid at 541428:1, pH 5.6). LTs were then resolved by isocratic reverse-phase HPLC on a Novapak C,8 column (3.9 X 150 mm; Waters Associates) in the mobile phase at a flow rate of 1.2 mL/min. The column effluent was monitored by on-line measurement of the absorbance at 280 nm. LTs were identified by retentiontime matching to synthetic standards, and quantities were adjusted to the recovery of the internal standard, PGB,.
Measurement of LTC, Synthase Enzymatic Activity
Butyric acid-differentiated HL-60#7 cells were harvested, washed with dPBS, and resuspended at 10 X IO6 cells/mL in dPBS containing l mmol/L EDTA and 1 mg/mL D-glucose. Cells were incubated with 200 pmol/L cytokine for 30 minutes at 37°C and subsequently with CaCI, (2 mmol/L final concentration) for 8 minutes at 3 7 T , as described above. Acivicin (2.5 mmol/L) and LTAl (5 pmoll L, unless otherwise indicated) were added to the incubation mixture and, after 4 minutes at 37°C with gentle shaking, the reaction was stopped by combining the mixture with an equal volume of cold methanol containing 0.9 nmoYmL PGBz. LTs were enriched by solid-phase extraction and resolved by isocratic HPLC, as described above.
Analysis of GM-CSF and IL-5 Binding to HL-60#7 Cells
HL-60#7 cells, differentiated by growth in the presence of butyric acid for 5 to 6 days, were harvested, washed with dPBS, and resuspended to a final density of 40 X lo6 cells/mL in dPBS containing 0.1% (wdvol) BSA and 0.2% (wt/vol) sodium azide. Unless indicated otherwise, equilibrium binding mixtures containing 4 X IO6 cells and 1.0 nmol/L radioiodinated ligand ([Iz5I]rhGM-CSF or ['251]-rhIL-5) were incubated in the presence or absence of 100-fold molar excess rhGM-CSF or rhIL-5, respectively, for 60 minutes at 37°C with gentle orbital shaking. Cells were harvested by centrifugation at 6,600g for 90 seconds and washed twice with 1 mL dPBS containing 0.1% (wt/vol) BSA. Resuspended pellets and combined supernatants were counted for 1 minute in a gamma counter to measure the cell-associated and free radioactivity, respectively. Specific binding to differentiated HL-6W7 cells was deduced by subtracting nonspecific radioligand binding (samples with rhGM-CSF or rhIL-5 present) from total radioligand binding (no rhGM-CSF or rhlL-5 present).
Western Blot Detection of Phosphorylated Tyrosines
Butyric acid-differentiated HL-60#7 cells were harvested and treated with 200 pmoVL rhGM-CSF, rhIL-5, or dPBS (as a control) for 30 minutes at 37°C as described above. An equivalent aliquot (600 pL) from each incubation mixture was removed, centrifuged 
RESULTS
rhGM-CSF Priming Increases the Rate of LT Formation in Ionophore-Challenged Eosinophilic HL-60#7 Cells Differentiated With Butyric Acid
A pro-eosinophilic substrain of the myelocytic leukemia cell line HL-60 (HL-60#7) was differentiated with butyric acid and used as a model for studying LT biosynthesis in eosinophils. These cells resemble eosinophils in many different aspects. Morphologically, butyric acid-differentiated HL-6W7 cells have prominent eosin-staining granules that contain eosinophil major basic protein and eosinophil peroxidase. Functionally, eosinophilic HL-6W7 cells are chemotactic and respond to mediators with similar rank orders of potency as eosinophils (RANTES >PAF >LTB, >C5a >LTD4 >fMLP). These cells also express pertinent cytokine and LT receptors (IL-5, RANTES, GM-CSF, LTB,, and LTD,) as well as relevant cysteinyl leukotriene biosynthetic enzymes such as LTC4 ~ynthase.~'
As has been observed for eosinophils isolated from peripheral human blood, this cell line synthesizes predominantly cysteinyl LTs when stimulated with the calcium ionophore A23187 (Fig l) .'3 Because cytokines appear to mediate activation of LT biosynthesis in mature myeloid cells,!"' the effects of cytokine pretreatment on this eosinophilic cell line were investigated. Priming of HL-60#7 cells with rhGM-CSF was found to enhance ionophore-stimulated LT biosynthesis in a dose-dependent manner (ED5,, = 150 pmol/L), reaching a maximum at 200 to 400 pmoVL rhGM-CSF (Fig  2A) . HL-6W7 cells incubated with PBS (control), rhGM-CSF, or rhIL-5 for 30 minutes before calcium ionophore challenge showed that rhGM-CSF priming increased total LT biosynthesis by about 45%, whereas rhIL-5 had no effect on the formation of LTs (Fig 2B) . LT biosynthesis could not be primed with concentrations of IL-5 tested in the range of 3 pmoYL to l nmol/L (data not shown).
Because cytokines are involved in cellular differentiation as well as activation, their effects may differ depending on the stage of cell maturation. To initiate differentiation, HL-6W7 cells were cultured for a varying number of days with butyric acid, which converts pro-eosinophilic cells towards mature eosinophilic cells. The ability of these cells to produce LTs after ionophore challenge was then measured with or without rhGM-CSF or rhIL-5 pretreatment (Fig 3) . After 5 days of culturing cells with butyric acid, the rhGM-CSF priming effect was maximal, whereas rhIL-5 pretreatment had no effect on LT production regardless of the stage of differentiation.
To determine if rhGM-CSF affected the amount of LTs produced or their rate of biosynthesis, HL-6W7 cells were preincubated in the presence or absence of rhGM-CSF and then, after varying times subsequent to ionophore challenge, total LT formation was measured (Fig 4A) . In the absence of rhGM-CSF priming, LT biosynthesis occurred at a steady rate, reaching a maximum 10 minutes after ionophore challenge. Pretreatment with rhGM-CSF increased the rate of LT production without affecting the total amount of LTs formed. In both cases, subsequent degradation was observed. The maximum LT production in rhGM-CSF-primed cells occurred 3 minutes after ionophore-challenge. Similar results were obtained measuring only cysteinyl LTs (Fig 4B) . 
v GM-CSF or IL-5 Pretreatment
It is possible that rhGM-CSF may enhance LT formation by upregulating one of the enzymes in the LT biosynthesis pathway. LTC, synthase is the first committed enzyme in the cysteinyl LT half of this biosynthetic pathway. As such, this enzyme may play a pivotal role in the regulation of LT biosynthesis in cytokine-treated eosinophilic cells. LTCJ synthase has recently been purified to homogeneity and its N-terminal amino acid sequence was subsequently deduced." A protein kinase C (PKC) consensus sequence was identified within the amino-terminus of LTCJ synthase and, consistent with this finding, LTC, synthase has been shown to be negatively regulated after cellular PKC activation. 33 To determine if cytokine-stimulated phosphorylation events could modulate LT biosynthesis in HL-60#7 cells, the effects of rhGM-CSF or rhIL-5 pretreatment on the K,,, and V,,., of LTCs synthase in HL-60#7 cells was investigated (Fig S ) . HL-60#7 cells were pretreated with rhGM-CSF or rhIL-5 for 30 minutes and subsequently incubated in the presence of varying concentrations of LTA,, a cosubstrate for LTC, synthase, and acivicin, an inhibitor of the y-glutamyl transpeptidase that converts LTC, to LTD,. After 4 minutes of incubation at 37°C. the amount of LTC., produced was measured by isocratic reverse-phase HPLC. The kinetic parameters, K,,, and V,,,,,, of LTC, synthase were found to be unaltered when HL-60#7 cells were pretreated with either rhGM-CSF or rhIL-5. Thus, these cytokines do not affect cysteinyl LT production by altering the activity of LTCJ synthase.
Differential Activation of Eosinophilic HL-60#7 Cells GM-CSF and IL-5 rhGM-CSF was able to prime LT production in eosinophilic HL-60#7 cells, whereas rhIL-5 was not (see above). pmol/L rhlL-5. Calcium (2 mmol/L final concentration) was then added t o the mixture, which was incubated for an additional 8 minutes. Calcium ionophore, A23187, was added t o a final concentration of 1 pmol/L and the reaction was stopped after 3 minutes at 37°C by combining the mixture with an equal volume of ice-cold methanol containing 0.2 nmol/mL PGB,. LTs were purified by solidphase extraction with Sep-Pak Cl S cartridges and resolved by isocratic reverse-phase HPLC as described in Materials and Methods. Data are expressed as the mean 2 SE of four separate experiments each performed in triplicate and analyzed using Kruskal-Wallis and Mann-Whitney U statistical tests.
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This finding was unexpected because we have previously shown that eosinophilic HL-60#7 cells contain high-affinity Initially, the time course of appearance of ['*'I]rhGM-CSF or ['*'I]rhIL-5 binding sites on HL-60#7 cells at various stages of eosinophilic differentiation was investigated. Cells were cultured for a varying number of days in butyric acid and then subsequently incubated with radioligand in the presence or absence of 100-fold excess of unlabeled competing ligand to ascertain the nonspecific and total binding, respectively. Specific binding was deduced by subtracting the nonspecific binding from the total bound. ['251]rhIL-5 and [1251]-rhGM-CSF specific binding to HL-60#7 cells increased at similar rates with increasing days in culture with butyric acid, reaching a maximum after 5 days of differentiation (Fig 6) . This result corresponded to the optimum priming effect previously observed with rhGM-CSF (Fig 3) . Because maximum specific binding was obtained after culturing HL-6#7 cells for 5 days with butyric acid, these 5-day differentiated cells were used to produce saturation binding curves.
HL-60#7 cells were incubated with varying concentrations of ['251]rhGM-CSF (Fig 7A) or ['251]rhIL-5 (Fig 7B) in the presence or absence of 100-fold excess of unlabeled competing ligand and the specific binding was again determined by the difference between the total bound and the nonspecific bound. Upon Scatchard transformation of the resulting saturation binding isotherms, it was found that GM-CSF and IL-5 each displayed a single population of high-affinity binding sites on eosinophilic HL-60#7 cells with dissociation constants of 86 and 25 pmol/L, respectively. GM-CSF and IL-5 receptor binding sites were also shown to be present on the cells in equivalent abundance, with about 200 receptor sites per cell. Therefore, the differential priming effects of rhCM-CSF versus rhIL-5 on LT biosynthesis cannot be explained by a difference in the population of high-affinity receptors.
GM-CSF and IL-S receptor populations in eosinophilic HL-60#7 cells cannot be cross-competed. GM-CSF and IL-5 cytokine receptors both consist of a specific a-chain and a common P-chain c~mponent.'~^*' On the surface of the cell membrane, these subunits must somehow form a complex, either before or after ligand binding. One possibility that might account for the differential priming effect of GM-CSF versus IL-5 on LT formation may be due to a difference between the stability of the respective GM-CSF and IL-5 ligand-receptor complexes, although the similarity of I<d values argues against this possibility. A more stable ligand-receptor complex may facilitate the receptor's ability to transduce a signal, leading to increased LT biosynthesis after ionophore challenge as a result of cytokine priming. (Fig 8A) or ['251]rhIL-5 (Fig 8B) were incubated in the presthe cell assodated radioadvity. MC binding to differentiated ence of varying concentrations of unlabeled rhIL-5 or rhGM- ling pathways affecting LT formation was investigated. GM-CSF and IL-5 are known to rapidly induce tyrosine phosphorylation, indicating the involvement of protein tyrosine kinases that may be important for signal t r a n s d~c t i o n .~'~ Thus, to determine if GM-CSF and IL-5 have different signaling mechanisms, phosphotyrosine patterns produced from incubating eosinophilic HL-60#7 cells with dPBS (control), rhGM-CSF, or rhIL-5 were analyzed using a specific phosphotyrosine monoclonal antibody, 4G10 (Fig 9) . The pattern of phosphorylated tyrosines exhibited by rhGM-CSF incubation was different from that produced by treatment with rhIL-5. Several proteins were found to be tyrosine phosphorylated in the presence of rhGM-CSF that were not detected from cells treated with rhIL-5. Thus, the tyrosine phosphorylation patterns suggest that GM-CSF and IL-5 signal differently in this cell line.
data, along with the determination of similar dissociation
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DISCUSSION
Eosinophils are major producers of cysteinyl LTs in the lung and have been implicated in the tissue destruction associated with the late phase of a~t h m a . ' .~~.~ The biosynthesis of LTs by these cells has also been shown to be enhanced by the presence of ~ytokines.''.'~ Thus, the control of LT production through cytokine signal transduction mechanisms may substantially affect the pathogenicity associated with eosinophil activation. In this study, the effects of cytokines on LT formation in eosinophilic HL-60#7 cells were investigated to determine their mechanism of regulation of LT biosynthesis.
Similar to previous results with eosinophils derived from circulating blood, pretreatment of eosinophilic HL-60#7 cells with GM-CSF primed the calcium-ionophore-stimulated biosynthesis of total LTs in a dose-dependent manner. Interestingly, this enhancement appeared to be due to an increase in the rate of LT formation rather than the overall amount of LTs produced, although the possibility that high concentrations of ionophore may mask later events cannot be excluded. These results correlate well with the ability of this cytokine to enhance LT biosynthesis in other systems such as neutrophils and basophils, as was shown by the upregulation of five-lipoxygenase activating protein (FLAP) mRNA by GM-CSF in neutrophils:' Because the release of such mediators is almost instantaneous upon stimulation, the priming of LT biosynthesis could increase the quantity of mediators immediately available for release in activated cells.
The enhancement in the rate of LT biosynthesis by GM-CSF was initially speculated to be caused by an increase in   SCOGGAN, FORD-HUTCHINSON, AND NICHOLSON the activity of LTC, synthase. LTC, synthase was a probable candidate because it represents the first committed enzymatic step in the LT biosynthetic pathway leading to the production of cysteinyl LTs. Eosinophils predominantly produce the cysteinyl LTs, LTC,, LTD,, and LTE,, and this bias in LT formation has been characterized to be an increase in the activity of LTC, synthase upon terminal differentiation towards an eosinophil." Further analysis of LTC, synthase lead to the discovery of a PKC consensus sequence present in the N-terminus of this protein3* and that PKC activation negatively modulated activity.3' GM-CSF may consequently be capable of priming LT biosynthesis by upregulating LTC, synthase via its PKC consensus sequence through phosphorylation/dephosphorylation events. However, unexpectedly, neither GM-CSF nor IL-S had any effect on LTC, synthase activity. The kinetic parameters, K,,, and V , , , , were unaltered in the presence of GM-CSF or IL-S, indicating that these cytokines do not enhance LT biosynthesis by increasing the activity of LTC, synthase. and FLAP e x p r e s s i~n ? '~~~ It has also been shown that phospholipase AZ activity in neutrophils can be upregulated by GM-CSF!3 Furthermore, GM-CSF priming may elevate the pool of arachidonic Thus, GM-CSF pretreatment of eosinophilic HL-60#7 cells may enhance LT biosynthesis of ionophore-stimulated cells by upregulating the activity and expression of proteins that occur earlier on in the biosynthetic pathway.
One of the most interesting observations of this study was that GM-CSF was capable of priming LT biosynthesis in eosinophilic HL-60#7 cells, whereas IL-5 had no effect on LT formation. This result was in contrast to those of previous experiments that showed both GM-CSF and IL-5 priming of LT production in eosinophil^.^^'^^'^'^ Receptor binding studies confirmed that the differential priming effect observed between GM-CSF and IL-5 was not simply due to differences in receptor populations or affinities for their respective ligands. Both GM-CSF and IL-5 high-affinity receptors were present on these cells in equal populations. The difference in the ability of GM-CSF versus IL-5 to prime LT biosynthesis was also shown not to be due to a discrepancy in the stability of their respective receptor complexes. Despite the fact that these heterodimeric receptors share a common P subunit that is necessary for high-affinity conversion and for signal transduction, neither GM-CSF nor IL-5 was capable of competing for the other's receptor binding sites, indicating that the stability of the ligand-receptor complex was not a factor in determining the LT priming ability of GM-CSF over IL-5.
Because the differential priming effect could not be resolved by receptor binding studies, it was postulated that GM-CSF and IL-5 may have distinct signalling mechanisms in these cells. Analysis of phosphotyrosine patterns produced in the presence of GM-CSF or IL-5 suggests that these cytokines may be signalling differently or that IL-5 is unable to transduce a signal in this cell line. At least three distinct bands were tyrosine phosphorylated by treatment with GM-CSF that were not present in IL-5-treated or control cells. These observations suggest that the specific a-chains of the receptors may play a role in diverse signalling mechanisms. Other studies have shown that, although the a-chain is incapable of signalling alone, it is required for the P-chain to ~ignal.~'.~' It has been suggested that the a-chain confers specificity not only to receptor binding but also to the signal transduced by the receptor.48 Another possible explanation for differences in the ability of GM-CSF versus IL-5 to signal intracellularly is the possibility of alternative splicing events that occur after transcription of the receptors' mRNAs. HL-60#7 cells may contain an alternate form of the IL-5 receptor a-chain that is capable of high-affinity binding but not intracellular signalling, although neither Northern blots nor the cDNA sequences of the a -and preceptor subunits cloned from this cell line show any abnormalities (data not shown).
In summary, GM-CSF was able to prime LT biosynthesis in eosinophilic HL-60#7 cells by enhancing their rate of LT production in a dose-dependent manner. GM-CSF had no effect on the activity of LTC4 synthase but may have upregulated the activity of 5-lipoxygenase or phospholipase AZ enzymes that occur earlier in the LT biosynthetic pathway. Unexpectedly, IL-5 was incapable of a similar priming effect. This unconventional priming effect was not a result of different receptor populations or differences in the affinity or stability of the ligand-receptor complexes of GM-CSF and IL-5. Analysis of phosphotyrosine patterns suggests that IL-5 is incapable of transducing a signal in eosinophilic HL-60#7 cells even though IL-5 and GM-CSF both share a common P-chain component of their receptors that is believed to be responsible for signal transduction. Overall, this unique system may permit the dissection of distinct events that are responsible for the specific intracellular signals transduced separately by GM-CSF or IL-5.
